» Articles » PMID: 36418116

Perspectives on the COVID-19 Vaccine Uptake: a Qualitative Study of Community Members and Health Workers in Zambia

Abstract

Objective: Since introduction of the programme in April 2021, COVID-19 vaccine uptake has been low at less than 20%. This study explored community members' and health workers' perspectives on the COVID-19 vaccine uptake and its influencing factors in Zambia.

Study Design: A qualitative study employing focus group discussions (FGDs) and in-depth interviews (IDIs).

Study Setting: Sixteen primary healthcare facilities selected from Lusaka, Copperbelt, Central and Southern provinces.

Participants: A total of 32 FGDs comprising local community members and 30 IDIs including health workers, traditional, religious and civic leaders (n=272). FGDs were separated based on age (youth and adults), sex (male and female) and place of residence (urban and rural).

Results: Both FGD and IDI participants agreed that vaccine uptake was low. Limited knowledge, access to information, myths and misconceptions, negative attitude, low-risk perception and supply in remote areas affected vaccine uptake. Overall, FGD participants expressed limited knowledge about the COVID-19 vaccine compared with health workers. Further, FGD participants from urban sites were more aware about the vaccine than those from rural areas. Health workers perceived the vaccine to be beneficial; the benefits included prevention of infection and limiting the severity of the disease. Moreover, FGD participants from urban sites expressed a negative attitude towards the vaccine. They believed the vaccine conferred no benefits. By contrast, participants from rural communities had mixed views; they needed more information about the vaccine benefits. Participants' attitude seems to have been influenced by personal or family experience with the COVID-19 disease or vaccination; those who had experienced the disease had a more positive attitude. In contrast, most young people believed they were not at risk of the COVID-19 disease. Misinformation from social media influenced their attitude.

Conclusion: These results provide starting points for future policies and interventions for increasing COVID-19 vaccine uptake.

Citing Articles

Determinants of COVID-19 vaccination acceptance based on the novel Omale INDEPT FORCIS Framework and recommendations for subsequent pandemics: a qualitative study among community members in Ebonyi state, Nigeria.

Omale U, Adeke A, Oka O, Ikegwuonu C, Iyare O, Nnachi O Int J Equity Health. 2024; 23(1):223.

PMID: 39468612 PMC: 11520843. DOI: 10.1186/s12939-024-02284-3.


Feasibility of Provision and Vaccine Hesitancy at a Central Hospital COVID-19 Vaccination Site in South Africa after Four Waves of the Pandemic.

Nair S, Tshabalala K, Slingers N, Vanleeuw L, Basu D, Abdullah F Diseases. 2024; 12(6).

PMID: 38920545 PMC: 11202450. DOI: 10.3390/diseases12060113.


Perceptions of yellow fever emergency mass vaccinations among vulnerable groups in Uganda: A qualitative study.

Huebl L, Nnyombi A, Kihumuro A, Lukwago D, Walakira E, Kutalek R PLoS Negl Trop Dis. 2024; 18(5):e0012173.

PMID: 38739650 PMC: 11115279. DOI: 10.1371/journal.pntd.0012173.


Euvichol-plus vaccine campaign coverage during the 2017/2018 cholera outbreak in Lusaka district, Zambia: a cross-sectional descriptive study.

Mukonka V, Sialubanje C, Matapo B, Chewe O, Ngomah A, Ngosa W BMJ Open. 2023; 13(10):e070796.

PMID: 37798024 PMC: 10565249. DOI: 10.1136/bmjopen-2022-070796.


Uptake of four or more doses of sulfadoxine pyrimethamine for intermittent preventive treatment of malaria during pregnancy in Zambia: findings from the 2018 malaria in pregnancy survey.

Sinyange D, Mukumbuta N, Mutale L, Mumbole H, Hamainza B, Sialubanje C BMJ Open. 2023; 13(5):e073287.

PMID: 37236665 PMC: 10231002. DOI: 10.1136/bmjopen-2023-073287.


References
1.
Kavanagh M, Gostin L, Sunder M . Sharing Technology and Vaccine Doses to Address Global Vaccine Inequity and End the COVID-19 Pandemic. JAMA. 2021; 326(3):219-220. DOI: 10.1001/jama.2021.10823. View

2.
Mahmud S, Mohsin M, Khan I, Mian A, Zaman M . Knowledge, beliefs, attitudes and perceived risk about COVID-19 vaccine and determinants of COVID-19 vaccine acceptance in Bangladesh. PLoS One. 2021; 16(9):e0257096. PMC: 8428569. DOI: 10.1371/journal.pone.0257096. View

3.
Roghani A . The Influence of COVID-19 Vaccination on Daily Cases, Hospitalization, and Death Rate in Tennessee, United States: Case Study. JMIRx Med. 2021; 2(3):e29324. PMC: 8363125. DOI: 10.2196/29324. View

4.
Dagan N, Barda N, Kepten E, Miron O, Perchik S, Katz M . BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting. N Engl J Med. 2021; 384(15):1412-1423. PMC: 7944975. DOI: 10.1056/NEJMoa2101765. View

5.
MacDonald N . Vaccine hesitancy: Definition, scope and determinants. Vaccine. 2015; 33(34):4161-4. DOI: 10.1016/j.vaccine.2015.04.036. View